A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1994
12/08/1994	WO1994027964A1 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists
12/08/1994	WO1994027961A1 N-alkylthio polyamine derivatives as radioprotective agents
12/08/1994	WO1994027957A1 Compounds which release nitric oxide
12/08/1994	WO1994027954A1 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
12/08/1994	WO1994027952A1 Novel antiviral agents
12/08/1994	WO1994027641A1 Amplification of the vitamin b12 uptake system using polymers
12/08/1994	WO1994027632A1 Cell growth regulators
12/08/1994	WO1994027626A1 Method for decreasing calcium uptake by cells
12/08/1994	WO1994027624A1 Formulations which comprise vitamins and minerals for preventing cancer
12/08/1994	WO1994027621A1 Iron-binding polymers for oral administration
12/08/1994	WO1994027620A1 Compositions and process for removing bile salts
12/08/1994	WO1994027619A1 Process for adjusting ion concentration in a patient and compositions therefor
12/08/1994	WO1994027618A1 Methods for the treatment and prevention of diarrhea
12/08/1994	WO1994027616A1 L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents
12/08/1994	WO1994027614A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
12/08/1994	WO1994027613A1 Vitamin b12 mediated oral delivery systems for gcsf and epo
12/08/1994	WO1994027611A1 Intramuscular and subcutaneous injection solution for animals
12/08/1994	WO1994027610A1 Agents containing a compound with an anti-androgen effect and a compound with a competitive, progesterone-antagonistic effect
12/08/1994	WO1994027609A1 Dihydrotestosterone for use in androgenotherapy
12/08/1994	WO1994027608A1 Methods and compositions for inducing sleep
12/08/1994	WO1994027607A1 Antiviral agent
12/08/1994	WO1994027606A1 Method of treating helicobacter pylori infection
12/08/1994	WO1994027605A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
12/08/1994	WO1994027603A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
12/08/1994	WO1994027602A1 Use of metabotropic receptor agonists in progressive neurodegenerative deseases
12/08/1994	WO1994027600A1 Pharmaceutical formulations with clavulanic acid and an antimycobacterial agent
12/08/1994	WO1994027599A1 Rectal compositions
12/08/1994	WO1994027596A1 Pharmaceutical preparation and method of producing it
12/08/1994	WO1994027595A1 Tri(platinum) complexes
12/08/1994	WO1994027594A2 Stable copper(i) complexes and methods related thereto
12/08/1994	WO1994027593A1 Use of 12-deoxyphorbol 13-monoesters for inhibiting neoplasia and tumor promotion
12/08/1994	WO1994027592A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue
12/08/1994	WO1994027591A1 Therapeutic substituted guanidines
12/08/1994	WO1994027590A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis
12/08/1994	WO1994027589A2 Antidepressant dosage form
12/08/1994	WO1994027588A1 Methods and compositions for treating depression and other psychiatric disorders
12/08/1994	WO1994027587A2 Sustained antiepileptic therapy
12/08/1994	WO1994027586A1 Inhibition of hair growth
12/08/1994	WO1994027585A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
12/08/1994	WO1994027584A2 Arylating medicaments
12/08/1994	WO1994027583A2 Apoptosis inhibitors for treating neurodegenerative diseases
12/08/1994	WO1994027582A1 A drug delivery composition for alpha-adreno receptor blocking agents
12/08/1994	WO1994027579A1 Ulcer treating composition
12/08/1994	WO1994027577A1 Liquid antacid compositions
12/08/1994	WO1994027576A1 Nasal drug delivery composition containing nicotine
12/08/1994	WO1994027563A1 Inhibition of hair growth
12/08/1994	WO1994027533A1 Stable suppository formulations effecting biovailability of δ9-thc
12/08/1994	WO1994027440A1 Anti-infective agents
12/08/1994	WO1994027435A1 Genetic immunization with cationic lipids
12/08/1994	WO1994027433A1 Synthetic media for blood components
12/08/1994	WO1994024163A3 Bispecific antigen-binding molecules
12/08/1994	WO1994023638A3 Diagnosis and treatment of supravalvular aortic stenosis and williams syndrome
12/08/1994	WO1994016096A3 Method to predict active growth of bacteria adhered to a surface
12/08/1994	WO1994012165A3 Enzyme inhibitors
12/08/1994	CA2698716A1 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods
12/08/1994	CA2337581A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds and intermediates in the preparation therefor
12/08/1994	CA2163966A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
12/08/1994	CA2163887A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
12/08/1994	CA2163878A1 Agents containing a compound with an anti-androgen effect and a compound with a competitive, progesterone-antagonistic effect
12/08/1994	CA2163867A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use
12/08/1994	CA2163772A1 Intramuscular and subcutaneous injection solution for animals
12/08/1994	CA2163741A1 Peptide inhibitors of urokinase receptor activity
12/08/1994	CA2163640A1 Stable copper (i) complexes and their use as active therapeutic substances
12/08/1994	CA2163638A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
12/08/1994	CA2163459A1 Arylating medicaments
12/08/1994	CA2163450A1 Embryotoxic factors
12/08/1994	CA2163372A1 5-ht4 receptor antagonists
12/08/1994	CA2163340A1 A drug delivery composition for alpha-adreno receptor blocking agents
12/08/1994	CA2163227A1 Vitamin b12 mediated oral delivery systems for gcsf and epo
12/08/1994	CA2163226A1 Amplification of the vitamin b12 uptake system using polymers
12/08/1994	CA2163089A1 Nasal drug delivery composition containing nicotine
12/08/1994	CA2162921A1 Carbazole derivatives with 17, 20-lyase-inhibiting activity
12/08/1994	CA2162488A1 Triazole derivative or salt thereof, and antifungal agent containing the same
12/08/1994	CA2162467A1 Use of dihydroliponic acid as an ophthalmologic agent and for the suppression of incompatability reactions at the interfaces between implants and living body tissue
12/08/1994	CA2161769A1 Substituted oxazolyl compounds for the treatment of inflammation
12/08/1994	CA2161649A1 4-amino-17.beta.-cyclopropyloxy)androst-4-en-3-one, 4-amino-17.beta.- (cyclo propylamino)androst-4-en-3-one and related compounds as c17-20 lyase and 5. -reductase inhibitors
12/08/1994	CA2157186A1 Antidepressant dosage form
12/08/1994	CA2140532A1 Tricyclic cefem sulphones as elastase inhibitors
12/08/1994	CA2140519A1 Taxane having antitumor activity
12/08/1994	CA2125077A1 Imidazopyridine
12/07/1994	EP0627490A1 Method for the preparation of long-chain inulin
12/07/1994	EP0627441A1 Crystalline 2-0-alpha-D-glucopyranosyl-L-ascorbic acid, and its preparation and uses
12/07/1994	EP0627438A1 Methanediphosphonate derivative, process for producing the same, and pharmaceutical use thereof
12/07/1994	EP0627432A1 6-Piperazinyl-1H-pyrazolo [3,4-b]pyridine-3-carboxylic Acids, Esters, Amides andrelated compounds, a process for their preparation and their use as medicaments
12/07/1994	EP0627430A1 Process for converting loracarbef dihydrate to loracarbef monohydrate
12/07/1994	EP0627429A1 Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
12/07/1994	EP0627427A1 3-Quinolyl substituted dihydropyridines, process for their preparation and their use in drugs
12/07/1994	EP0627419A1 Optically active 1-phenylpyrrolidone derivative, intermediate for producing the same, and process for producing both
12/07/1994	EP0627418A1 N-subtituted 2-azetidinones and processes for the production of N-unsubstituted 2-azetidinones therefrom
12/07/1994	EP0627413A1 Substituted benzoylguanidines, process for their preparation, their use as medicaments as well as medicament containing them
12/07/1994	EP0627407A1 (7S)-7-(2(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them
12/07/1994	EP0627400A1 Aromatic acetylcholinesterase inhibitors
12/07/1994	EP0627259A2 Silicone containing oil-in-water emulsions
12/07/1994	EP0627222A1 Infusion and injection compositions containing dexamethasone-21-phosphate-disodium salt and polysorbate
12/07/1994	EP0627221A2 Substance P antagonists for the treatment of emesis
12/07/1994	EP0627220A1 Pharmaceutical compositions for the treatment of thalassemia
12/07/1994	EP0627219A1 Use of calmodulin inhibitors for neuroprotection
12/07/1994	EP0627001A1 MAMMALIAN Sos - A REGULATOR/EFFECTOR OF TYROSINE KINASE SIGNALLING
12/07/1994	EP0626969A1 CoA-IT AND PAF INHIBITORS
12/07/1994	EP0626968A1 Piperidinyl thiacyclic derivatives

1 ... 7060 7061 7062 7063 7064 7065 7066 7067 7068 7069 7070 7071 7072 7073 7074 7075 7076 7077 7078 7079 7080 ... 7860